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Abstract
Background: Multiple randomized controlled trials (RCTs) show that behavioral lifestyle interventions are effective
in improving diabetes management and that comprehensive risk factor management improves cardiovascular
disease (CVD) outcomes. The role of technology has been gaining strong support as evidence builds of its potential
to improve diabetes management; however, evaluation of its impact in minority populations is limited. This study
intends to provide early evidence of a theory-driven intervention, Tablet-Aided BehavioraL intervention EffecT on
Self-management skills (TABLETS), using real-time videoconferencing for education and skills training. We examine
the potential for TABLETS to improve health risk behaviors and reduce CVD risk outcomes among a low-income
African American (AA) population with poorly controlled type 2 diabetes.
Methods: The study is a two-arm, pilot controlled trial that randomizes 30 participants to the TABLETS intervention
and 30 participants to a usual care group. Blinded outcome assessments will be completed at baseline, 2.5 months
(immediate post-intervention), and 6.5 months (follow-up). The TABLETS intervention consists of culturally tailored
telephone-delivered diabetes education and skills training delivered via videoconferencing on tablet devices, with two
booster sessions delivered via tablet-based videoconferencing at 3 months and 5 months to stimulate ongoing use of
the tablet device with access to intervention materials via videoconferencing slides and a manual of supplementary
materials. The primary outcomes are physical activity, diet, medication adherence, and self-monitoring behavior, whereas
the secondary outcomes are HbA1c, low-density lipoprotein cholesterol (LDL-C), BP, CVD risk, and quality of life.
Discussion: This study provides a unique opportunity to assess the feasibility and efficacy of a theory-driven, tablet-aided
behavioral intervention that utilizes real-time videoconferencing technology for education and skills training on
self-management behaviors and quality of life among a high-risk, low-income AA population with an uncontrolled dyad
or triad of CVD risk factors (diabetes with or without hypertension or hyperlipidemia). The intervention leverages the use
of novel technology for education and skill-building to foster improved diabetes self-management. The findings of this
study will inform the process of disseminating the intervention to a broader and larger sample of people and can
potentially be refined to align with clinical workflows that target a subsample of patients with poor diabetes
self-management.
Trial registration: The trial was registered in April 2014 with the United States National Institutes of Health
Clinical Trials Registry (ClinicalTrials.gov identifier NCT02128854), available online at: http://clinicaltrials.gov/ct2/
show/NCT02128854.
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Background
The southeastern “Diabetes and Stroke Belt” of the US
has a high rate of mortality attributed to independent
risk factors for cardiovascular disease (CVD) [1, 2], such
as diabetes, hypertension, dyslipidemia, and stroke. South
Carolina (SC) has one of the highest proportions of
African American (AA) residents (28 %) compared to the
national prevalence (13 %). In addition, AAs face higher
risks of heart disease and stroke-related deaths more often
than Whites. AAs are 67 % more likely to have diabetes
and had a stroke mortality rate that was 56 % higher than
the national average in 2006 [3]. Behavioral risk factors
such as poor diet, physical inactivity, and low medication
adherence are strongly linked to adverse CVD events.
Racial/ethnic differences in CVD risk factors show AAs to
have up to a twofold risk of poor control of glycemia,
blood pressure, and lipids compared to Whites [4, 5].
Thus, minority populations, AAs in particular, are more
likely to suffer poor diabetes and CVD outcomes [6–10].
Updated guidelines for secondary prevention of CVD
present compelling evidence that comprehensive risk
factor management (pharmacologic and behavioral inter-
ventions) improves survival, reduces recurrent events and
the need for interventional procedures, and improves
quality of life [11]. However, providers face increasingly
limited time to focus on individual self-care among those
with multiple comorbidities. This study’s approach focuses
on enabling self-management behaviors through a
multi-component, tablet-aided behavioral intervention
that supports self-reliance and behavior change as a po-
tential solution to lowering CVD risk among people with
diabetes.
Multiple randomized controlled trials (RCTs) show that
behavioral lifestyle interventions are effective in improving
diabetes and CVD outcomes [12–16]. A review of three
large clinical trials with multifactorial interventions tar-
geting CVD risk among people with diabetes revealed
significant improvements in achieving good diabetes
self-management behaviors (control of blood pressure
[BP], lipids, glycemia [glycosylated hemoglobin A1c,
HbA1c], weight, and medication adherence) [17], sug-
gesting that interventions targeting multiple CVD risk
factors have a larger impact on CVD risk reduction
than single risk factor interventions. Although multiple
concurrent and consecutive behavior adjustments can
be tremendously difficult to learn and to maintain for
patients [18], cross-cutting approaches to multi-morbid
conditions will help advance chronic disease manage-
ment [19]. A systematic review of coping skills training
and problem-solving interventions in people with
diabetes showed significantly improved diabetes self-
management for better metabolic outcomes [20, 21].
Ultimately, problem-solving skills become an integral
part of self-management education that helps empower
patients to identify problems, adopt strategies to take
action, and modify their actions based on different cir-
cumstances [22]. The current literature supports the
idea that patient-level factors are the key to disease
management [23–25] and implementing behavioral in-
terventions with problem-solving and skills training
components in high-risk adults is effective in reducing
CVD outcomes.
The role of technology has been gaining strong sup-
port as evidence builds of its effectiveness for diabetes
management [26, 27]. The utility of advanced communi-
cation technology in health care is in facilitating medical
encounters, increasing access to health care services,
and broadening availability of resources, even among
underserved populations. Several studies have shown at
least equivalent effectiveness of computer-aided [28],
telehealth [29, 30], and mobile-enabled interventions on
improving diabetes self-care [31] and glycemic control
[25, 27]. Another randomized study of 636 patients
examined the extent of BP control attained through
implementing a multi-component, telephone-delivered,
behavioral self-management intervention, home BP
monitoring, combined intervention, and usual care [32].
This study showed a significant BP-lowering effect from
the combined intervention compared to usual care with a
mean of 10 telephone calls (standard deviation, or SD = 3)
and a mean call length of 16 minutes (SD = 7); the separ-
ate interventions showed no difference. Patients often
prefer to rely on these information and communication
modalities for access to health care resources and for initi-
ating positive changes in their health behaviors. Yet, the
role of technology in minority populations is limited to
telehealth interventions that target problem-solving skills
[33, 34], which reduces office visits but does not allow
consistent daily support to facilitate learning adaptive
behaviors for good diabetes self-management (DSM).
Studies that focus on AA participants will help to fill
a gap in the literature on how behavioral inter-
ventions can use technology to better impact self-
management of diabetes and other cardiovascular risk
factors in this specific subpopulation [25], which gen-
erally has poorer glycemic control and higher mortal-
ity rates [10]. The proposed study provides early
evidence of the theory-driven, Tablet-Aided Behav-
ioraL intervention EffecT on Self-management skills
(TABLETS), using real-time videoconferencing for
education and skills training, on improving chronic
disease self-management (CDSM) behaviors and CVD
risk among a high-risk, low-income AA population.
Rationale
Resources are limited for many AAs in SC, given the
disproportionately greater poverty and lower education
among AAs compared to Whites [35]. Our pilot RCT
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will maximize the reach and effect of the intervention
and will improve CDSM behaviors (physical activity,
diet, medication adherence, self-monitoring) without
exceeding available resources [18]. The TABLETS inter-
vention targets control of these modifiable risk behav-
iors. We use motivational enhancement strategies for
low-income AA adults to help them develop a skill set
that achieves and maintains good behavioral and clinical
outcomes. Potentially successful patient-focused strategies
can utilize technology as a tool [31] for personalized learn-
ing experiences, and as rapidly interactive and mutually
convenient modes of communication between patients
and providers [36]. The proposed project will present early
evidence of the effectiveness of a multi-component inter-
vention targeting CDSM behaviors using a tablet-based
delivery approach for high-risk, low-income AAs. Tablet-
aided delivery of the behavioral intervention is best for
several reasons: (1) the tablet has a larger visual display to
facilitate use among older minority adults — the demo-
graphic at highest risk for diabetes, (2) there is greater
accessibility of health services and resources for low in-
come populations, and (3) technology-enabled interven-
tion has the added value of convenience, portability,
multi-tasking, and personalization, as studies show
promising results with small improvements in clinical
outcomes among people with diabetes [37, 38]. This pro-
ject will yield valuable data in preparation for a large-
scale RCT to assess whether the lifestyle intervention, in
conjunction with tablets as a behavior augmentation tool,
has strong potential for promoting long-term behavior
change and chronic disease management in underserved
populations.
Study aim and objectives
The primary aim is to examine the efficacy of a multi-
component TABLETS intervention on improving be-
havioral outcomes (physical activity, diet, medication
adherence, self-monitoring) in high-risk, low-income
AAs with type 2 diabetes using a pilot RCT design. The
secondary aims examines the efficacy of the multi-
component TABLETS intervention on improving CVD
risk profiles and health-related quality of life among
high-risk, low-income AAs with type 2 diabetes.
Methods
The study is a two-arm, pilot RCT with 1:1 randomization
of 60 AA participants. Blinded assessments are made at
baseline (immediate post-randomization), 2.5 months, and
6.5 months (follow-up). Two booster sessions are de-
livered via tablet-based videoconferencing at 3 months
and 5 months to stimulate ongoing use of the tablet
device with access to intervention materials via video-
conferencing slides and the web-based portal.
Location and setting
The study sites are the general internal medicine, endo-
crine, family medicine, and community care clinics affili-
ated with the Medical University of South Carolina in
Charleston, SC, an urban academic medical center. All
screening and assessment activities were held at a re-
search lab. The study team, including the study principal
investigator (PI) or co-I, a study coordinator, research
assistant (RA), nurse health educator (NHE), and bio-
statistician, meet frequently to review the study protocol
and progress, conduct trainings, and manage unforeseen
issues.
Ethics and trial registration
The study is funded by grant number R03DK098489
from the National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK). The trial is approved by
the Institutional Review Board (IRB) of the Medical
University of South Carolina.
Trial population and recruitment
A total of 60 African Americans (AAs) with type 2 dia-
betes mellitus (T2DM) are being randomized to one of
two groups. One study group (n = 30) receives the
TABLETS intervention, which consists of culturally
tailored, telephone-delivered diabetes education and
skills training delivered via videoconferencing on tablet
devices. The other study group (n = 30) receives usual
care as provided by their primary care provider (PCP).
Two complementary approaches are used to identify
eligible study participants. The first method consists of
systematic identification of AA patients with T2DM.
After obtaining approval from the IRB, and partial
waiver of HIPAA from our local IRB, we use medical or
billing records from the prior 6 months to identify (or
prescreen) patients with ICD-9 codes for diabetes
[250.xx] and hypertension [401.0] or hyperlipidemia
[272.0]. The physicians of eligible patients are notified
of their patients’ potential eligibility and asked permis-
sion to enroll their patients in this study. After consent
is obtained from the physicians, letters of invitation on
clinic letterhead signed by the patient’s physician are
mailed to patients from the study clinics. The letter
provides information about the study, explains the
study requirements, and clarifies that only patients who
meet certain criteria are eligible to participate in the
study. The letter includes an addressed and stamped
postcard that patients can mail back to indicate interest
or lack of interest in participating in the study. In
addition, the letter provides a telephone number that
interested patients can call to receive detailed informa-
tion about the study. In the letter, patients are also in-
formed that they will receive a follow-up call in
2 weeks unless they mail back the postcard or call to
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decline being contacted. Patients who mail back the
postcard and express interest or call the provided tele-
phone number receive detailed information about the
study. Patients who agree to participate are asked to
provide written consent and are scheduled for the ini-
tial screening assessment.
The second method consists of referrals from physi-
cians, other clinic staff such as nurses, or patients
themselves in response to recruitment flyers for the
study. The PI shares the goals of the study and inclu-
sion/exclusion criteria with physicians and clinic staff
during clinic administrative meetings. Physicians and
clinic staff are asked to refer appropriate patients to the
study research assistants. In addition, IRB-approved re-
cruitment flyers are posted in prominent locations in
the study clinics.
Regardless of the recruitment pathway, research staff
members obtain written informed consent, complete
screening for eligibility, and ensure that participants
meet criteria for inclusion and participation in the
study. The procedure and risks are explained to the pa-
tients and the consent form signed as per standard
practice. Eligibility has been determined as meeting the
following inclusion criteria: self-identified black or Afri-
can American; age ≥45 years; clinical diagnosis of
T2DM (by ICD-9 code of 250.xx) with an HbA1c ≥8 %
at screening; clinical diagnosis of hypertension and
blood pressure (BP) >140/80 mmHg at the screening
visit or clinical diagnosis of hyperlipidemia and low-
density lipoprotein cholesterol (LDL-C) >100 mg/dL at
screening; able to communicate in English; residence in
a 4G cellular service area; and access to a telephone
(landline or cell phone). Exclusion criteria include men-
tal confusion or impairment during screening using the
validated Mini-Cog instrument [39]; participation in
other clinical trials related to the subject area; alcohol
or drug abuse/dependence; active psychosis; acute
decompensation of chronic conditions that preclude
participation; and life expectancy <6 months. Partici-
pants who meet eligibility criteria then complete the
remainder of the assessment battery and undergo
randomization.
Randomization
All participants are randomly assigned to one of the
two study arms (n = 30 per arm) using a permuted
block randomization method: (a) TABLETS interven-
tion and (b) usual care (UC). Block size is varied to
minimize the likelihood that the blind is broken. The
randomization is stratified by baseline HbA1c levels
(8–10 % versus >10 %). The RA collects eligibility infor-
mation and enters the information into the study data-
base via the secured study website. Once eligibility is
confirmed, a computer program developed by the
biostatistician (RGK) generates the intervention assign-
ment based on the preprogrammed randomization
scheme with the order of assignment placed in sealed
envelopes until informed consent to participate is
signed and eligibility criteria are met. All participants
who are randomized are entered into the study data-
base and analyzed according to CONSORT guidelines,
as shown in Fig. 1 [40].
Intervention and control groups
All study participants continued routine clinical visits
with their primary care physicians to receive the stand-
ard of care.
TABLETS intervention
The proposed TABLETS intervention builds on the core
components of an existing culturally tailored diabetes
intervention [41], but it broadens the scope to address
multiple CVD risk factors and adds a novel tablet-based
delivery mechanism to provide real-time videoconferenc-
ing education about DSM behaviors to high-risk, low-
income AA adults with diabetes. Intervention participants
receive a complimentary manual of documents arranged
in specific sections to provide (1) instructions on the use
of tablets and biometric measurement devices (glucometer,
sphygmomanometer, weight scale) and information about
CVD; (2) logs to support self-monitoring of blood glucose,
blood pressure, nutrition/dietary plans, and behavior
changes; and (3) brief education sheets to enhance behav-
ioral skills for lifestyle change such as tips for safe exercis-
ing, practical dietary modifications, reading nutrition
labels, and stress management. CVD knowledge/informa-
tion modules consist of materials developed from a CVD
patient education booklet adapted from the Maine Heart
Center of Maine Health [42] and supplemented by clinical
guidelines to specifically address behavioral risk factors
(that is, the four intervention components). Motivation
and behavioral skills training modules consist of patient
activation (asking questions to providers), patient em-
powerment (CVD responsibility contracts, flow charts for
lab results), and behavioral skills training (self-monitoring,
goal-setting). Culturally tailored components have evolved
from understanding the food content, social practices, and
acceptable forms of physical activity in the southern urban
AA culture. In addressing sociocultural and environmental
factors [43, 44], it becomes necessary to change or modify
usual interventions to the unique needs of rural individuals
in order to maximize its effectiveness in changing behav-
iors such as physical activity, diet, and self-monitoring.
Cultural tailoring of the proposed intervention has
involved aligning specific components with food prefer-
ences in southern cuisine, incorporating social interactions
in churches and/or among families and friends, and
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including physical activities AA participants were willing
to engage in over time.
Usual care group
Participants randomized to the UC group receive usual
care for diabetes management as provided by their PCP
and generally defined by the American Diabetes Associ-
ation clinical practice guidelines. When considering clin-
ical relevance and future directions, we decided it was
critical to establish that the TABLETS intervention is bet-
ter than usual care and that results are due primarily to
the intervention, since previous studies have established
the effectiveness of individual components. Thus, we
chose the pilot RCT design to examine whether the effect
of the TABLETS intervention exceeds that of UC and the
results are not due to time trends or other alternative rea-
sons. The issue of attention control was considered with
this group. However, it was decided that comparing the
intervention to true usual care, as it reflects current clin-
ical practice during the time of this study, would provide a
clearer sense of the intervention’s effectiveness in changing
behavior and more accurate estimates of cost outcomes.
Technology of individual intervention sessions
Each participant in the intervention group receives one
tablet computer and three biometric measurement devices
(glucometer with adapter, sphygmomanometer, and weight
scale; see figure). The tablet is provided to participants
enclosed in a case that allows it to recline on a flat surface
and facilitate viewing during weekly videoconference edu-
cation sessions. In the 2-week run-in phase, participants
were instructed to use the tablet device and navigate the
internal functionality (use of a predefined set of apps in-
cluding an email app), check their email to ensure receipt
and retrieval of messages sent to them, and use the Inter-
net app to explore information on the web. Participants
are allowed to use the Internet on tablets to web browse
with restrictions. During videoconferencing, the NHE sim-
ultaneously screen shares slides to reinforce major learning
points and, when needed, can also use a whiteboard fea-
ture to allow a visual for simple mathematical calculations.
Participants are asked to use the biometric measurement
devices to monitor their blood sugar and blood pressure
on at least a daily basis and their weight on a twice-weekly
basis. Each of the measurement devices transmits readings
wirelessly to a cellular modem (see Fig. 2) that forwards
data to a web-based portal database. The NHE accesses
the portal prior to each intervention session to review the
prior weeks’ readings with participants. Participants are
also able and encouraged to access the portal and view
their own readings in a tabular or graphical format on the
tablet and have the option to do the same on their person-
ally owned computer. In addition, the NHE can enter, save,
and push reinforcing or celebratory messages to partici-
pants such as “Good job keeping track of your numbers”,
Fig. 1 CONSORT flow diagram
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“We can work on getting your blood pressure in range”, or
“Happy Birthday!”.
Content of individual intervention sessions
Intervention sessions comprise a multimedia collection
of communication tools including (1) interactive video-
conferencing segments to deliver education and skills
training, (2) supplemental videoconferencing slides, and
(3) a whiteboard that provides visual aids aligned with
educational materials. Presentations incorporate the par-
ticipant’s CVD risk factor data and their 10-year CVD
risk based on Framingham Risk Score (FRS) [45] esti-
mates, according to seven factors (age, gender, total
cholesterol (TC), high-density lipoprotein cholesterol
(HDL-C), systolic BP, anti-hypertensive medication use,
and smoking status).
Session 1
Session 1 is designed to be a face-to-face encounter with
the NHE to review study goals and the schedule of study
sessions, obtain participant contact information (primary
and alternate telephone numbers), establish a schedule
for follow-up calls, and receive study materials. For the
intervention group, subsequent sessions comprise educa-
tion and skills training (15 minutes of content delivery
followed by 15 minutes of skills training) for interactive
learning. The comparator group receives usual care pro-
vided by their primary care physician.
Sessions 2–9
Each of the eight main intervention sessions falls under
one of three areas of focus as described below.
Information: The NHE reviews the CVD education
booklet with participants and provides visual examples
of items such as a sample nutrition label and prede-
fined menu with healthy alternatives. Education is also
provided on increasing fruit/vegetable/fiber intake, lim-
iting fat/cholesterol/salt intake, and minimizing added
sugars; and building up physical activity to moderate
intensity as aligned with guidelines (American Diabetes
Association [46], American Heart Association (AHA)
Diet and Lifestyle Recommendations [47], AHA/Ameri-
can College of Sports Medicine [48]). Information is
provided on medication effects/side effects and strat-
egies for self-monitoring. All education modules are de-
signed to be relevant and person-centered. Motivation:
Embraces patient activation and empowerment and
works toward goals to improve communication skills
with health care providers by asking questions at clinic
visits about setting goals for A1c, BP, and cholesterol,
reviewing monitoring logs, or need to change medica-
tions. The NHE is trained to empower patients by pro-
viding tools for CVD self-management guided by their
“Heart Health Care Package,” which contains a respon-
sibility contract; personal goals sheet; listing of good
health practices; self-management kit; flow sheets for
lab results/medications; and blood sugar and BP logs.
Behavioral skills: Aims to equip participants with the
skills needed to increase self-efficacy and behavior change
through a series of skills training sessions with the NHE,
who emphasizes individualized problem-solving. Skills
training is based on the four DSM behaviors and review of
home monitoring devices (including blood glucose, blood
pressure, and pedometer readings) along with medication
adherence strategies and tracking data via portal. Guided
by participants’ problem areas and preferences, the NHE
assists participants in the process of choosing weekly tar-
get goals for each behavior over 8 weeks with action plans.
During each session the NHE implements strategies
learned during motivational enhancement training.
Sessions 10–11
Two booster sessions are delivered on tablets at 3 and
5 months post-randomization, during which the NHE
reviews goals from action plans, discusses problem-
solving, and implements motivational strategies for DSM
behaviors.
The NHE participates in routine training by a psych-
ologist (KJR) with expertise in behavioral activation and
motivational enhancement. The training involves learn-
ing motivational skills through discussion of relevant
materials, case-based scenarios, role-playing, and stra-
tegic alignment of motivations of study participants.
This training facilitates the NHE in developing and re-
fining the skills to empower patients in engaging with
their PCPs as well as understanding their numbers and
problem-solving for their own self-management using
Fig. 2 Technology Package of Biometric Measurement Devices with
Associated Cellular Modem
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the tools provided in the Heart Health Care Package de-
scribed above.
Individuals from the study’s intervention group are
asked to participate in 30- to 40-minute, semi-structured
interviews by telephone to assess usability outcomes for
the tablet computer and its associated peripheral measure-
ment devices that help with refinement of the interven-
tion. All interviews are audio-recorded to ensure accuracy
of data and for anonymous use of selected verbatim
quotes. Therefore, all participants will have acknowledged
and agreed through the informed consent process that
their participation in interviews requires their consent to
be audio-recorded, and they are asked to provide verbal
agreement at the time of the interview. After each session,
audio recordings are downloaded into a secure, password-
protected database developed for this study and later tran-
scribed into a word processing file that is stored on the se-
cure, password-protected web databases developed for
this study. Approval from the IRB was obtained prior to
audio-recording any interviews.
Study instruments and data collection schedule
See Fig. 3 for the study design and study flow and Ta-
bles 1, 2, and 3 for the data collection schedule, data col-
lection measures, and data collection instruments,
respectively. The RA, who was blinded to group assign-
ment, conducted study assessments at baseline and at
2.5 and 6.5 months post-randomization. The NHE pre-
sented the randomized group assignment to each par-
ticipant and performed the study intervention sessions.
All blood samples were analyzed at the central labora-
tory of the academic medical center.
Study outcomes
The primary outcome is behavioral self-management
including physical activity, diet, medication adherence,
and self-monitoring. The secondary outcomes are
clinical measures for glycemic (HbA1c), BP, and lipid
control (LDL-C); CVD risk assessed by Framingham
Risk Score (FRS) [45]; and quality of life assessed by
Medical Outcomes Study (MOS) Short Form (SF-12)
[49]. Each outcome was measured at baseline, 2.5 months
(immediate post-intervention) and 6.5 months for follow-
up (post-randomization).
Sample size determination and power analysis
Pilot studies are generally not sufficiently powered to de-
tect statistically significant effect sizes [50]; however,
small differences in primary outcome results can offer a
signal of benefit and will be necessary justification that it




Compared to high-risk, low-income AAs with diabetes
receiving UC, individuals randomized to the multi-
component TABLETS intervention will have greater im-
provement in behavioral outcomes at the 6.5 months
follow-up.
The intent-to-treat (ITT) sample, comprising all ran-
domized participants, is used for primary analyses. A
two-tiered analysis strategy is used for the primary and
secondary aims (comparing efficacy of the TABLETS
intervention compared to UC on improving the primary
and secondary outcomes among high-risk AA adults).
First, each primary outcome (physical activity, diet,
medication adherence) and each secondary outcome
(HbA1c, BP, LDL, Framingham Risk Score) is assessed
separately over the 6-month study time trajectory using
longitudinal data methods (generalized linear mixed ef-
fects modeling, GLMM) to compare the longitudinal tra-
jectory of the outcomes for the two intervention groups.
Fig. 3 Study design and flow
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Table 1 Data collection schedule
Questionnaires/measurements Screening visit Baseline visit 2.5 months visit 6.5 months visit
Primary outcome measures
Physical activity (GPAQ) x x x
Diet (REAPS) x x x
Medication adherence (MMAS) x x x
Self-monitoring behavior x x x
Secondary outcome measures
HbA1c x x x
LDL cholesterol x x x
Blood pressure x x x
CVD risk (FRS) x x x
Quality of life (SF-12) x x x
Process measures
Knowledge/information x x x
Motivation x x x
Behavioral skills x x x
Self-efficacy x x x
Empowerment x x x
Tablet usability x x x
Covariates
Patient demographics x
Medical comorbidity (chronic health conditions – BRFSS) x x x
Social support (MOS) x x x
Health literacy (s-TOFHLA) x x x
Brief literacy screener (Chew) x x x
Depression (PHQ-9) x x x




Physical activity Measured by the 16-item Global Physical Activity Questionnaire (GPAQ) [57]
Diet Dietary intake assessed using the Rapid Eating and Activity Assessment for Participants Short
Version (REAP-S) [58]
Medication adherence Measured with the 8-item self-report Morisky Medication Adherence Scale (MMAS) [59]





Blood specimens obtained at baseline, 2.5 and 6.5 months visits
Blood pressure (BP)
measurements
An average of three BP readings done in 2-minute intervals obtained at baseline, 2.5 and
6.5 months by a trained RA using automated BP monitors (OMRON IntelliSenseTM HEM-907XL)
with the patient seated comfortably for 5 minutes prior to the measurements
Cardiovascular disease risk Framingham Risk Score (FRS) estimates the 10-year risk of “hard” coronary heart disease
outcomes (myocardial infarction, death) [45]
Quality of life The SF-12 is a valid and reliable instrument to measure functional status and will be used to
assess quality of life at baseline, 2, and 6 months assessments. The SF-12 items reproduce at
least 90 % of the variance in PCS-36 and MCS-36 scores [49]
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GLMM can accommodate different distributional as-
sumptions for outcome variables (for example, continu-
ous, dichotomous, or ordinal outcomes) [51] and missing
data [52]. In further secondary multivariable analyses, add-
itional covariables will be added to the model to adjust for
putative confounding variables, if appropriate. Candidate
covariables include, for example, age, gender, and educa-
tion. Least squares means will be compared at relevant
time points (2.5 and 6.5 months) using appropriate model
contrasts. Second, the global benefit of the intervention
based on multiple primary outcomes (physical activity,
diet, medication adherence) and secondary outcomes
(HbA1c, BP, LDL-C, Framingham Risk Score) will be
assessed using a global statistical test (GST) [51].
An important role of a pilot study is to evaluate issues
related to feasibility. Intervention feasibility measures in-
clude recruitment, compliance, and dropout proportions.
For the intervention group, 95 % confidence intervals
for proportions will be used to estimate the proportion
of those enrolled versus those eligible, the proportion of
adherers to the intervention protocol, and the propor-
tion of drop-outs. We will describe patients’ reasons for
refusing to participate and reasons for dropping out to
get a better understanding of the barriers to recruitment
and to implementation, respectively. Dropout propor-
tions between the TABLETS and UC groups will be
compared using logistic regression analyses.
Qualitative data management and analysis
In the final 6.5 months assessment, those in the inter-
vention group will be asked to participate in 30- to 40-
minute, semi-structured interviews by telephone. This is
an optimal time to explore participants’ perspectives,
insights, needs, and preferences in their own terms [53]
as they apply to intervention components (physical ac-
tivity, diet, medication adherence, self-monitoring). Just
as patient-physician encounters can be examined for
context cues [54], research staff will use a summary of
the main context cues in the four topic areas to address
what worked or did not work (useful, useless compo-
nents); what enabled or delayed behavior changes (facili-
tators, barriers); the most helpful strategies (education,
motivation, skills training) to resolve challenges; and
usability and satisfaction with the tablet as a self-
monitoring tool. Interview methods allow flexibility to
gather additional details when needed and will yield data
to refine the intervention for future implementation.
With IRB approval, all interviews are audio-recorded for
accuracy of data and use of selected verbatim quotes.
Prior to closing, key responses are summarized, and par-
ticipants are asked if they have anything to add. All data
will be stored on a secure server for analysis.
Inductive data analyses will be performed to examine
the natural variation among the themes, patterns, and
categories that emerge from semi-structured interviews.
The NVivo 10 qualitative management program used for
this study is designed to systematically facilitate coding,
sorting, and integrating all of the data. Two coders (in-
cluding the PI) will review the transcripts and apply
codes (words or brief text describing context) guided by
the conceptual model and intervention components in
order to provide concepts used in generating the initial
line-by-line codes [55]. Triggers for important words,
concepts, and comments will be noted as well as their
consistency among participants. The two sets of codes
will then be reviewed to determine agreement (called
Table 3 Data Collection for Intermediate Measures and Covariates
Measure Data collected Method
Process and behavioral
measures
Information Measured by the 29-item CVD Knowledge Questionnaire [61]
Motivation Measured by the brief Intrinsic Motivation Inventory (IMI) [62]
Behavioral
skills
Assessed with the 13-item Cardiac Self-Efficacy scale [63]
Self-efficacy Measured by 10-item General Self-Efficacy scale [64]
Empowerment Measured by 28-item Diabetes Empowerment Scale-Short Form (DES-SF) [65, 66]
Tablet usability Measured by the modified System Usability Scale (SUS) [67]
Covariates Demographics Previously validated items from the 2002 National Health Interview Survey are used to capture age, gender,
race/ethnicity, marital status, household income, and health insurance
Medical
comorbidity
Medical comorbidity is documented using previously validated items on chronic health conditions from the
Behavioral Risk Factor Surveillance System (BRFSS, 2010) [68]
Social support The Medical Outcomes Study (MOS) Social Support Survey [69] is used to measure social support
Health literacy The short form of the Test of Functional Health Literacy in Adults (s-TOFHLA) [70] is designed to rapidly
screen patients for potential health literacy problems. The 3-item Chew Health Literacy Screening Survey will
also be used [71]
Depression The PHQ-9 is a brief questionnaire that scores each of the 9 DSM-IV criteria for depression [72]
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inter-coder reliability). Differences in interpretation of
codes will be discussed and resolved between study in-
vestigators. An iterative process of coding will result in a
final set of codes that can subsequently be applied to tran-
scripts to identify themes common within and across par-
ticipant interviews [55]. The goal is to address important
questions that have not been examined before, to “tell a
story” about the participants in this study, and to
conceptualize participants’ knowledge of physical activity
and diet, coping and skill-building, and ability to act on
self-monitored data. Findings will help refine the interven-
tion and emphasize elements that enhance participant up-
take and motivation for sustained behavior change.
Discussion
The study was funded in September 2013. Progress has
been made in identifying and building relationships with
technology companies, streamlining novel information
technology processes to accommodate the multimedia
aspect of the intervention (tablets, videoconferencing,
home monitoring devices), refinement of intervention
materials, obtaining needed study equipment (such as
tablet computers with the technological capacity to exe-
cute the planned intervention), and hiring and training
research personnel. The overarching goal is to develop
and refine intervention processes and materials that
allow tablet-based delivery of education and skills train-
ing about self-management behaviors relevant to CVD
risk using real-time videoconferencing among AA adults
with diabetes and other CVD risk factors. Study recruit-
ment was initiated in September 2014 with eligibility de-
termination, randomization, and enrollment currently
underway.
The proposed study provides a unique opportunity to
assess the feasibility and efficacy of a theory-driven,
tablet-aided behavioral intervention that utilizes real-
time videoconferencing technology for education and
skills training on chronic disease self-management be-
haviors and CVD risk among a high-risk, low-income
AA population with an uncontrolled dyad or triad of
CVD risk factors. In the evolution of a paradigm shift to
become more person-centered in the provision of care
and to drive sustainable behavior change [56], the behav-
ioral intervention in this pilot study is adding important
value to the literature on facilitating healthier self-
management behaviors. The intervention will leverage
the use of a novel technology for education and skill-
building that fosters improved diabetes self-management
in a high-risk AA population. The findings of this study,
if successful, will provide the basis for disseminating the
intervention to a broader and larger sample of people,
and can potentially be refined to align with clinical
workflows that target a subsample of patients with poor
diabetes self-management.
Trial status
At the time of submission, the study is in the final phase
of recruitment and enrollment. We have completed 92 %
of the target recruitment, 63 % have completed the first
(2 months) follow-up visit, and 43 % have completed the
second and final (6 months) follow-up assessment.
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